Try our Advanced Search for more refined results
Intellectual Property UK
-
September 25, 2025
Pfizer, BioNTech Challenge GSK Patents Over Vaccine Tech
Pfizer and BioNTech are suing GlaxoSmithKline Biologicals over a range of its patents linked to key processes in the manufacture of COVID-19 vaccines, arguing that the substances were not novel when GSK patented them.
-
September 25, 2025
Telegraph Voids Businessman's 'Hongkong Telegraph' TM
The company behind The Telegraph has persuaded European Union officials to block a businessman's "Hongkong Telegraph" trademark application, proving that it comes too close to the British newspaper's name.
-
September 25, 2025
Paris Metro Can't Nix 'Strikingly Different' Italian 'TPlus' TM
The state body running Paris' public transport has failed to convince European officials that an Italian company's trademark for "TPlus" will encroach on its exclusive rights over "Ticket t+," since the marks left "strikingly different" impressions on travelers.
-
September 25, 2025
Man City Star Striker Haaland Wins Challenge To 'Haaland' TM
Erling Haaland has convinced European officials to nix a trademark application over his surname, after proving that a Polish applicant had just wanted to take advantage of his international reputation to sell watches, sports gear and yogurt.
-
September 25, 2025
Menswear Chain Moss Bros. Trumps Rival's 'Mosso' TM
British menswear chain Moss Bros. has convinced European Union officials to ax an Italian company's bid for the trademark "Mosso," finding that some consumers would struggle to tell the brands apart.
-
September 24, 2025
University Of Washington Loses DNA Sequencing Patent Bid
The University of Washington failed to convince European officials that it should get a patent for a method that reduces errors in a popular DNA sequencing technique, as it had added two new features that weren't in its original application.
-
September 24, 2025
Viatris Nixes Biogen's Extra 1-Year Protection Over MS Drug
A court agreed on Wednesday to cancel a European Commission decision that extended Biogen's market protection for the multiple sclerosis drug tecfidera for an extra year, allowing Viatris to enter the generics market months earlier.
-
September 24, 2025
The Lawyer Wins UK Trademark Clash With Danish Biz
Legal news website The Lawyer has dashed a Danish company's "The Lawyer Hub" U.K. trademark hopes, proving that its opponent filed its application in bad faith.
-
September 24, 2025
Takeda Gives Up Patent For Hunter Syndrome Treatment
Japanese pharmaceuticals company Takeda has given up its European patent for a Hunter syndrome treatment after an appeals panel suggested that the therapy was not inventive.
-
September 24, 2025
Sanofi Injects $625M Into VC Arm For AI Investment
French pharmaceutical giant Sanofi said Wednesday that it has committed $625 million to its corporate venture capital arm to invest in artificial intelligence, digital healthcare and early-stage biotech companies.
-
September 23, 2025
Ralph Lauren Bumps Rival Polo Player TM For Fashion Items
A Ralph Lauren subsidiary has convinced European officials to partially reject a rival mark for "Polo USA" alongside a polo player, after showing that the public might get confused by the "striking similarities" to its famous Ralph Lauren logo.
-
September 23, 2025
Premier League Scores TM Win In 'Summer Series' Fight
An event organizer has failed to persuade British officials to deny a trademark application from the company that runs the Premier League, because its use of the phrase "Summer Series" to market London boat parties wouldn't be seen as a trademark.
-
September 23, 2025
Paris Rodin Museum Takes Partial Victory In EU TM Fight
The Rodin museum in Paris has kept the majority of its trademark protections over its name in the European Union after fighting off a challenge from a Mexican paint company of the same name.
-
September 23, 2025
7-A-Side Football League Keeps 'Peluche Caligari' EU TM
Seven-a-side football competition Kings League has fought off a challenge to its European Union trademark covering the name of its "Peluche Caligari" team.
-
September 23, 2025
UK Gov't Names New IP Minister Amid AI Growth Push
The government named Kanishka Narayan as the new minister responsible for intellectual property on Tuesday, replacing Feryal Clark MP, as it looks to advance the U.K.'s push on IP and artificial intelligence.
-
September 23, 2025
Nokia Unit Loses Appeal For Network System Patent At EPO
A European appeals panel has rejected a Nokia subsidiary's attempt to revive its application for a network system patent, ruling in a decision released Tuesday that the tech isn't inventive.
-
September 22, 2025
UK Juice Co. Denies 'Boost' Trademark Infringement Claims
A U.K. juice bar company has denied the claims of an Australian rival that its use of the word "boost" in its marketing amounts to a trademark infringement, arguing that the word is simply descriptive and not protected by copyright.
-
September 22, 2025
Chinese Brand Beats French Retailer's 'IABI' TM Challenge
A Chinese business has fought off a challenge to its "IABI" trademark application, persuading U.K. officials that shoppers would not mix up the sign with a French clothing brand's "KIABI" branding.
-
September 22, 2025
Jewelry Co. Sues Rival For 'Almas Jewellers' TM Infringement
A jewelry supplier is suing a rival business in a London court, accusing it of stealing its "Almas Jewellers" trademark.
-
September 22, 2025
Instone Real Estate Beats Challenge To EU TM
A Portuguese property company has lost its challenge to German development business Instone Real Estate Group SE's trademark, after European Union officials found that differences between the signs would prevent confusion.
-
September 22, 2025
Solventum Unit Withdraws Wound Care Patent At EPO
Officials at the European Patent Office have ruled that a subsidiary of healthcare company Solventum Corp. cannot retain its patent for an adhesive cover used in wound care after the company withdrew its appeal during proceedings.
-
September 19, 2025
Gilead Fights Chinese Research Institute Over COVID Patent
American biopharmaceutical company Gilead is asking a London court to ax a Chinese military research institute's patent for a COVID-19 treatment, arguing that the drug was not a patentable invention.
-
September 19, 2025
Spanish Knife-Maker Can't Void TM From Ex-Employee's Biz
A European Union appeals panel has rejected a Spanish knife company's bid to block a trademark application from a former employee's new company, deeming the matter "irrelevant" to its scrutiny of the application.
-
September 19, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen brokerage firm ADS Securities file a fresh claim against German entrepreneur Lars Windhorst, AmTrust and Endurance Worldwide Insurance tackle an ongoing £50 million ($67 million) dispute over a failed litigation and insurance scheme, and Howard Kennedy LLP sue the son of a diamond tycoon over a £3.1 million legal bill.
-
September 19, 2025
Philip Morris Beats Challenge To 'Veev Now' E-Cig TM In EU
Philip Morris has persuaded a European Union appeals board not to quash its "Veev Now" e-cigarette trademark application, proving there is no risk of confusion with a Polish rival's earlier "Vivo" branding.
Expert Analysis
-
UK Patent Ruling Sharpens Contrast With US Practice
The U.K. Court of Appeal's decision last month in Regeneron v. Kymab is significant because it aligns the U.K.’s approach to the assessment of insufficiency with that of the European Patent Office. It also highlights, for U.S. companies, the stricter standard to which patent specifications are subject in Europe, say Edward Kelly and Regina Sam Penti of Ropes & Gray LLP.
-
IP Considerations For UK Open Banking App Developers
Since January of this year, consumer-facing banks in the U.K. have been required to make customers' banking data available to authorized third parties in a standardized format. As competition between open banking app developers increases, intellectual property rights will become a key legal tool, say Rajvinder Jagdev and Peter Damerell of Powell Gilbert LLP.
-
The Case For Early Mediation Or Arbitration In IP Disputes
Alternative dispute resolution is one of the best ways to resolve disputes involving patents, copyright, trademark, trade secrets and other intellectual property issues. While not every situation lends itself to ADR, it is more accessible than many parties assume, says Jerry Cohen of Burns & Levinson LLP.
-
International Arbitration In 2018: A Year Of Rule Revisions
Though still in its relative infancy, 2018 is shaping up to be a year of arbitral institution rule updates. Neil Newing and Ryan Cable of Signature Litigation LLP explore some of the more innovative and trending rule changes expected or predicted this year.
-
A Look At Chemical Supplemental Examination Requests
If used strategically, supplemental examination at the U.S. Patent and Trademark Office can provide a powerful tool for chemical patent owners to add to their armamentarium of options for Orange Book-listed patents when conducting a due diligence analysis of their patent estate prior to Orange Book listing, say attorneys with Finnegan Henderson Farabow Garrett & Dunner LLP.
-
Cloud-Based Patent Claims — And How Providers Can Help
Cloud customers may be exposed to liability for open source technologies that are buried deep within their providers’ offerings. In-house legal teams and developers need to be aware of the risk of patent litigation and the extent to which cloud providers can help mitigate these risks, says R. Paul Zeineddin of Zeineddin PLLC.
-
Comparing EU And US Standard-Essential Patent Guidance
The European Commission's long-awaited guidance on litigating and licensing standard-essential patents clarifies what conduct may insulate an SEP owner from abuse claims under competition law, in sharp contrast to the U.S., where the Federal Trade Commission and U.S. Department of Justice have declined to adopt any views on the subject, say Edward Kelly and Regina Sam Penti of Ropes & Gray LLP.
-
Strategic Considerations In Selecting Emergency Arbitration
In recent years, all of the major arbitral institutions have introduced an emergency arbitration procedure, yet studies suggest that parties rarely avail themselves of emergency arbitration and instead turn to local courts in times of crisis. Attorneys with Kirkland & Ellis LLP explore several considerations when determining where to pursue emergency relief.
-
Strategies For Protecting Biotechnology In Brazil And China
Brazil and China have taken important steps to become significant contributors to the future success of the bioeconomy. Understanding options for quickly procuring and challenging patents in Brazil and China can be key for companies looking to expand their bioeconomy investments outside the U.S. and Europe, say attorneys with Sterne Kessler Goldstein & Fox PLLC.
-
How The FTC Has Erred On Innovation Policy Issues
Maureen Ohlhausen, the acting chairman of the Federal Trade Commission, recently delivered a sobering attack on the agency, noting that it and other antitrust agencies have “lost sight of core antitrust principles.” From such a highly competent federal official who is also a recognized legal scholar, this critique deserves our full attention, says David Teece, chairman of Berkeley Research Group LLC.
-
Dairy Vs. Plant-Based 'Milks': A Regulatory Standoff
Sales of nondairy milk alternatives are flourishing, but the dairy industry charges the U.S. Food and Drug Administration with failing to enforce its own labeling regulations regarding the definition of "milk." The longer terms like soy milk, almond milk and coconut milk remain in use, the stronger the argument for their continued use to describe these products, say attorneys with Shook Hardy & Bacon LLP.
-
UK Supreme Court Broadens Scope Of Patent Protection
The U.K. Supreme Court’s recent judgment in Actavis v. Eli Lilly sets out a revised approach to assessing patents in the U.K. and is likely to confer greater protection on patent owners, by providing that the protection afforded to a patent is not limited to the wording of the claims, say attorneys with Dechert LLP.
-
Brexit Creates Uncertainty For IP
Following Brexit, if the EU regulations directly applicable to intellectual property law are not transposed into English or Scottish law, a regulatory vacuum could be created. For patents, this could mean the first lack of substantive legal protection in over 700 years, says Roberta Young of Loza & Loza LLP.
-
Guest Feature
An Interview With Floyd Abrams
It was a privilege to spend a half-hour on the phone with the nation's foremost First Amendment lawyer. Floyd Abrams and I discussed his career, his new book and what he sees in his free-speech crystal ball. And he was a very good sport when I asked if it is constitutionally protected to yell inside a movie theater: “Citizens United is a terrible decision and should be set on fire,” says Randy Maniloff of White and Williams LLP.
-
An Interview With Ex-USPTO Director Todd Dickinson: Part 2
During a recent conversation with us, Q. Todd Dickinson, former director of the U.S. Patent and Trademark Office, offered his thoughts on intellectual property legislative and judicial activity in recent years, the policies that could use improvement, and the challenges that lie ahead for patent holders, say David Haas and Scott Weingust of Stout Risius Ross LLC.